Study finds psoriasis treatment increases skin cancer risk

March 29, 2012
Study finds psoriasis treatment increases skin cancer risk
The long-term risk of squamous cell carcinoma is significantly increased for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A treatments compared with those who receive fewer than 50 treatments, according to research published in the April issue of the Journal of the American Academy of Dermatology.

(HealthDay) -- The long-term risk of squamous cell carcinoma (SCC) is significantly increased for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A (PUVA) treatments compared with those who receive fewer than 50 treatments, according to research published in the April issue of the Journal of the American Academy of Dermatology.

To investigate the association between PUVA exposure and SCC and (BCC) risk, Robert S. Stern, M.D., of Harvard Medical School in Boston, on behalf of the PUVA Follow-up Study, used data from 1,380 patients with severe psoriasis enrolled in a who were treated with PUVA.

The researchers found that, from 1975 to 2005, 25 percent of study participants developed 2,973 biopsy-proven SCCs and 24 percent developed 1,729 BCCs. The risk of developing one or more SCC in a year correlated strongly with the total number of PUVA treatments, after adjustment for confounders (350 to 450 versus <50 treatments, incidence rate ratio [IRR], 6.01). The risk was considerably higher when all tumors were included (IRR, 20.92). The risks for BCC were much lower (person counts IRR, 3.09; tumor counts IRR, 2.12).

"Exposure to more than 350 PUVA treatments greatly increases the risk of SCC," the authors write. "The risks of SCC in long-term PUVA-treated patients should be considered in determining the risk of this therapy relative to other treatments for severe psoriasis."

Explore further: Coffee consumption associated with decreased risk for basal cell carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Coffee consumption associated with decreased risk for basal cell carcinoma

October 24, 2011
Caffeine could be related to an inverse association between basal cell carcinoma risk and consumption of coffee, a study found.

Dose-Response link between tanning bed use, skin cancer

February 28, 2012
(HealthDay) -- Use of tanning beds, especially in high school and college, is associated with an increased risk of skin cancer, according to a study published online Feb. 27 in the Journal of Clinical Oncology.

Researchers find smoking is strongly associated with squamous cell carcinoma among women

December 8, 2011
Women who have non-melanoma skin cancers are more likely to have smoked cigarettes compared to women without skin cancer, said researchers at Moffitt Cancer Center in Tampa, Fla., who published study results in a recent issue ...

Vitamin D levels appear to be associated with risk of skin cancer, although relationship is complex

August 15, 2011
As an individual's level of vitamin D increases, the risk of nonmelanoma skin cancer (NMSC) seems to increase as well, although factors such as ultraviolet (UV) radiation exposure may complicate the relationship, according ...

IBD patients face increased skin cancer risk

November 21, 2011
Certain patients with inflammatory bowel disease (IBD) may have an increased risk of skin cancer, which is intensified by the use of immunosuppressant medications , according to two new studies in Gastroenterology, the official ...

Coffee, caffeine not linked to psoriasis in U.S. women

March 21, 2012
(HealthDay) -- Coffee and caffeine are not associated with psoriasis incidence after adjustment for smoking, according to a research letter published in the March issue of the Archives of Dermatology.

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.